Nathaniel Sisitsky - 15 Apr 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Apr 2026, 18:14:07 UTC
Prior SEC filing
31 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jennifer Ahn, attorney-in-fact for Nathaniel Sisitsky

Key filing fact

Nathaniel Sisitsky filed Form 4 for QuidelOrtho Corp (QDEL) on 22 Apr 2026.

Key facts

  • This page summarizes Nathaniel Sisitsky's Form 4 filing for QuidelOrtho Corp (QDEL).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 22 Apr 2026, 18:14.

Change

  • Previous filing in this sequence was filed on 31 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001225738 Primary reporting owner

SISITSKY NATHANIEL

Relationship
Chief Legal Officer
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO
Signature
/s/ Jennifer Ahn, attorney-in-fact for Nathaniel Sisitsky
Signature date
22 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+73,435
Change %
Price
$0.000000*
Shares after
73,435
Date
15 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
73,435
Exercise price
Footnotes
F1, F2
QDEL transaction Derivative

Non-Qualified Stock Options

Award

Transaction value
Shares
+73,434
Change %
Price
$0.000000*
Shares after
73,434
Date
15 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
73,434
Exercise price
$17.49
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F2

24,478 shares will vest in equal installments on April 15, 2027 and April 15, 2028; the remaining 24,479 shares will vest on April 15, 2029.

Footnote F3

24,478 shares will vest in equal installments on April 15, 2027, April 15, 2028 and April 15, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .